Inherited retinal disease study
Part of Eyes & vision, Genetic & congenital clinical trials.
This study follows people with inherited retinal diseases to learn how these conditions progress and how genetic changes relate to symptoms. It may help improve future care and treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had at least one eye exam and retinal imaging at our center.
- You have been diagnosed with an inherited retinal disease based on your family history, symptoms, or imaging.
- You have a confirmed genetic diagnosis from a reliable genetic test.
- You do not have other eye conditions like diabetic retinopathy or glaucoma.
- You have not taken certain medications that can harm the retina, such as hydroxychloroquine or tamoxifen.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at how people with inherited retinal disease that affects peripheral vision see and move around. It will test a new way to measure vision and navigation to see if it can help doctors understand how the disease affects daily life.
This study will check if certain vision tests work well in people with retinal diseases like retinitis pigmentosa or Stargardt. Results will help design future trials.
This study follows people with Stargardt disease (a genetic eye condition that causes vision loss) over time. It aims to learn more about how the disease progresses and does not test any treatment.
This study observes how Stargardt disease and similar eye conditions change over time in children and adults. It aims to learn more about the disease progression to help develop future treatments.
This trial tests a single injection of a new medicine, RTx-021, into the eye for people with Stargardt disease. The goal is to see if it is safe and to find the right dose.
This study tests a new way to measure vision, called MLSDT, in people with normal sight or vision loss from Stargardt disease or geographic atrophy (a type of advanced age-related macular degeneration). Results will help doctors better understand how well patients can see.
Hear when a new Stargardt Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.